Collective Family Office’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-4,226
| Closed | -$317K | – | 178 |
|
2023
Q3 | $317K | Sell |
4,226
-416
| -9% | -$31.2K | 0.12% | 126 |
|
2023
Q2 | $358K | Buy |
+4,642
| New | +$358K | 0.14% | 126 |
|
2023
Q1 | – | Sell |
-2,407
| Closed | -$207K | – | 171 |
|
2022
Q4 | $207K | Sell |
2,407
-1,696
| -41% | -$146K | 0.09% | 163 |
|
2022
Q3 | $253K | Sell |
4,103
-1,200
| -23% | -$74K | 0.13% | 149 |
|
2022
Q2 | $328K | Sell |
5,303
-5,675
| -52% | -$351K | 0.14% | 140 |
|
2022
Q1 | $653K | Buy |
10,978
+3,473
| +46% | +$207K | 0.25% | 102 |
|
2021
Q4 | $545K | Sell |
7,505
-367
| -5% | -$26.7K | 0.21% | 109 |
|
2021
Q3 | $550K | Sell |
7,872
-635
| -7% | -$44.4K | 0.24% | 97 |
|
2021
Q2 | $586K | Sell |
8,507
-444
| -5% | -$30.6K | 0.25% | 98 |
|
2021
Q1 | $579K | Sell |
8,951
-750
| -8% | -$48.5K | 0.28% | 91 |
|
2020
Q4 | $565K | Buy |
+9,701
| New | +$565K | 0.31% | 79 |
|